Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care
- PMID: 24343208
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care
Abstract
Rosacea is a common clinical diagnosis that encompasses a variety of presentations, predominantly involving the centrofacial skin. Reported to present most commonly in adults of Northern European heritage with fair skin, rosacea can affect males and females of all ethnicities and skin types. Pathophysiologic mechanisms that appear to correlate with the manifestation of rosacea have been the focus of multiple research studies, with outcomes providing a better understanding of why some individuals are affected and how their visible signs and symptoms develop. A better appreciation of the pathophysiologic mechanisms and inflammatory pathways of rosacea has allowed therapeutic strategies to be optimally incorporated. Part 1 of this 5-part series discusses the rosacea disease state with an emphasis on clinical correlation, reviews adjunctive skin care for cutaneous rosacea, and provides management caveats.
Similar articles
-
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.Cutis. 2013 Dec;92(6):277-84. Cutis. 2013. PMID: 24416742
-
Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy.J Dtsch Dermatol Ges. 2016 Dec;14 Suppl 6:4-15. doi: 10.1111/ddg.13139. J Dtsch Dermatol Ges. 2016. PMID: 27869372 Review.
-
Pediatric rosacea.Dermatol Ther. 2006 Jul-Aug;19(4):196-201. doi: 10.1111/j.1529-8019.2006.00075.x. Dermatol Ther. 2006. PMID: 17004995 Review.
-
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.Cutis. 2014 Jan;93(1):18-28. Cutis. 2014. PMID: 24505581
-
Rosacea and rhinophyma.Clin Dermatol. 2014 Jan-Feb;32(1):35-46. doi: 10.1016/j.clindermatol.2013.05.024. Clin Dermatol. 2014. PMID: 24314376 Review.
Cited by
-
Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society.Dermatol Ther (Heidelb). 2019 Dec;9(4):725-734. doi: 10.1007/s13555-019-00322-5. Epub 2019 Sep 11. Dermatol Ther (Heidelb). 2019. PMID: 31512178 Free PMC article.
-
The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.Acta Derm Venereol. 2021 Oct 31;101(10):adv00584. doi: 10.2340/actadv.v101.356. Acta Derm Venereol. 2021. PMID: 34643244 Free PMC article. Review.
-
An update on the treatment of rosacea.Aust Prescr. 2018 Feb;41(1):20-24. doi: 10.18773/austprescr.2018.004. Epub 2018 Feb 1. Aust Prescr. 2018. PMID: 29507456 Free PMC article. Review. No abstract available.
-
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).J Clin Aesthet Dermatol. 2020 Jun;13(6 Suppl):S17-S24. Epub 2020 Jun 1. J Clin Aesthet Dermatol. 2020. PMID: 33282106 Free PMC article.
-
Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.J Clin Aesthet Dermatol. 2021 Mar;14(3):E53-E57. Epub 2021 Mar 1. J Clin Aesthet Dermatol. 2021. PMID: 33841618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical